More than three in 10 healthcare leaders (38%) in Singapore are investing heavily in artificial intelligence in a bid to supercharge care in the city-state, the Philips Future Health Index 2022 report unveiled. Within the next three years, 74% of healthcare leaders expect AI to become a top investment area in the industry. Currently, healthcare leaders said their highest AI investment is for operational settings (16%), whilst only 12% invest in AI for clinical decision support which includes uses related to diagnosis or treatment recommendations, early warning scores, automatic disease detection and clinical decision guidelines. Others are investing in AI to integrate diagnostics (34%) and predict outcomes (32%). Whilst Singaporean healthcare leaders see AI as a key investment for the near future, many are already utilizing predictive analytics in some capacity, with almost half (45%) saying their hospitals or healthcare facilities have already adopted the technology.